The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 607-610

  Kinik, Sibel Tulgar ^a   Ataç, F Belgin ^a   Verdi, Hasibe ^a   Çetintaş, Sedat ^a   Şahin, Feride I ^a   Özbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; TURKEY (REPUBLIC);

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TURKEY;

EID: 18444372354     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02268.x     Document Type: Article

References (24)

1. Winkler, U.H. (1997) Obesity and haemostasis. Archives of Gynecology and Obstetrics, 261, 25-29.
2. Albisetti, M., Chan, A.K.C., McCrindle, B.W., Wong, D., Monagle, P. & Andrew, M. (2004) Impaired fibrinolytic activity is present in children with dyslipidemias. Pediatric Research, 55, 576-580.
3. Pittas, A.G., Joseph, N.A. & Greenberg, A.S. (2004) Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 89, 447-452.
4. Guerre-Millo, M. (2004) Adipose tissue and adipokines: for better or worse. Diabetes and Metabolism, 30, 13-19.
5. Estelles, A., Dalmau, J., Falco, C., Berbel, O., Castello, R., Espana, F. & Aznar, J. (2001) Plasma PAI-1 levels in obese children - effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thrombosis and Haemostasis, 86, 647-652.
6. Valle, M., Gascon, F., Martos, R., Bermudo, F., Ceballos, P. & Suanes, A. (2003) Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children. International Journal of Obesity, 27, 13-18.
7. Glowinska, B., Urban, M. & Koput, A. (2002) Cardiovascular risk factors in children with obesity, hypertension, and diabetes: lipoprotein (a) levels and body mass index correlate with family history of cardiovascular disease. European Journal of Pediatrics, 161, 511-518.
8. Sartori, M.T., Vettor, R., De Pergola, G., De Mitrio, V., Saggiorato, G., Delia Mea, P.D., Patrassi, G.M., Lombardi, A.M., Fabris, R. & Girolami, A. (2001) Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients: influence of fat distribution and insulin-resistance. Thrombosis and Haemostasis, 86, 1161-1169.
9. Eriksson, P., Kallin, B., Van't Hooft, F.M., Bavenholm, P. & Hamsten, A. (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 92, 1851-1855.
10. Hoffstedt, J., Andersson, L.L., Persson, L., Isaksson, B. & Arner, P. (2002) The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity. Diabetologia, 45, 584-587.
11. Doggen, C.J.M., Bertina, R.M., Cats, V.M., Reitsma, P.H. & Rosendaal, F.R. (1999) The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thrombosis and Haemostasis, 82, 115-120.
12. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
13. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, E, Zenere, M.B., Monauni, T. & Muggeo, M. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63.
14. Margaglione, M., Granda, E., Vecchione, G., Cappucci, G., Giuliani, N. & Colaizzo, D. (1997) Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2082-2087.
15. Mutch, N.J., Wilson, H.M. & Booth, N.A. (2001) Plasminogen activator inhibitor-1 and haemostasis in obesity. Proceedings of the Nutrition Society, 60, 341-347.
16. Samad, F., Uysal, T.K., Wiesbrock, S.M., Pandey, M., Hotamisligil, G.S. & Loskutoff, D.J. (1999) Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proceedings of the National Academy of Sciences of the United States of America, 96, 6902-6907.
17. 1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes, 49, 1374-1380.
18. Bastelica, D., Mavri, A., Verdier, M., Berthet, B., Juhan Vague, I. & Alessi, M.C. (2002) Relationship between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFα receptors to PAI-1 levels. Thrombosis and Haemostasis, 88, 481-487.
19. Skurk, T., van Harmelen, V., Lee, Y.M., Wirth, A. & Hauner, H. (2002) Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. Hormone and Metabolic Research, 34, 659-663.
20. Morange, P.E., Alessi, M.C., Verdier, M., Casanova, D., Magalon, G. & Juhan-Vague, I. (1999) PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 1361-1365.
21. Akar, N., Akar, E., Yilmaz, E. & Deda, G. (2001) Plaminogen-activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. Journal of Childhood Neurology, 16, 294-295.
22. Balta, G., Altay, C. & Gurgey, A. (2002) PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. American Journal of Hematology, 71, 89-93.
23. Epstein, F.H. (2000) Plaminogen-activator inhibitor type 1 and coronary artery disease. New England Journal of Medicine, 342, 1792-1801.
24. Ferguson, M.A., Gutin, B., Owens, C., Litaker, M., Tracy, R.P. & Allison, J. (1998) Fat distribution and hemostatic measures in obese children. American Journal of Clinical Nutrition, 67, 1136-1140.